8-K/A

AMENDMENT NO. 1 TO FORM 8-K

Company: Onconetix, Inc.
Filed: March 4, 2022
Period of Report: February 17, 2022
Accession Number: 0001213900-22-010779

View Document ↗ View on SEC.gov ↗